Cerca e trova il CMO / CDMO di cui hai bisogno
Discover highly skilled partners for your drug development and manufacturing project.
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Una struttura API e produzione intermedia approvata dalla USFDA.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Soluzioni CDMO one-stop per APl e intermediari chiave.
Location available after registration
COSMETICI manufacturing site
MAI network supplier
Impianto di fermentazione
Location available after registration
These facilities match your main criteria but not all optional filters.
SENN India | Non-GMP Plant | Hyderabad, India
Senn Chemicals
Sito di produzione non GMP su larga scala per intermedi peptidici, sintesi organica, operazioni LPPS e produzione su larga scala.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: COSMETICI, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIONE: APAC
SENN India | R&D Lab | Hyderabad, India
Senn Chemicals
Centro di ricerca e sviluppo per la chimica organica e dei peptidi con supporto per SPPS, purificazione, liofilizzazione, analisi e ingegneria delle particelle.
DIMENSIONE DEL LOTTO: Piccolo
SERVIZI: Analytical / QC services, Logistics, Development services, Packaging, Quality Assurance services
REGIONE: APAC
CATEGORIA / PRODOTTO: PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
Viswa Laboratories Pvt Ltd
Viswa Laboratories Private Limited
CRAMS/CDMO, API, intermedi e prodotti chimici speciali.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (M) Musculoskeletal system, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (D) Dermatologicals
SOSTANZE CONTROLLATE: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse
MERCATI: ANVISA (Brazil), CDSCO (India), Russian Health Authorities, EMA (EU), NMPA (China)
USO: Umano, Veterinario
COMPLIANCE: Organizzazione Mondiale della Sanità (GMP / HACCP)
REGIONE: APAC
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
SERVIZI: Manufacturing services, Development services
BSL (Livello di sicurezza biologica): 1, 2
CATEGORIA / PRODOTTO: CHEMICAL-SYNTHETIC
Pharmaron API Commercial Synthesis Shaoxing (China)
Pharmaron
Sintesi di piccole molecole/peptidi API commerciali.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services
REGIONE: APAC
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
MERCATI: FDA (USA), NMPA (China)
COMPLIANCE: FDA (cGMP), NMPA (Cina GMP), ISO
CATEGORIA / PRODOTTO: CHEMICAL-SYNTHETIC
MERCATI: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs, (V06) Nutrients
CATEGORIA / PRODOTTO: SERVICES, OLIGONUCLEOTIDI, CHEMICAL-SYNTHETIC
USO: Umano
COMPLIANCE: ANVISA (Brazil B-GMP), NMPA (Cina GMP)
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIONE: APAC
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
CARBOGEN AMCIS | Manchester, UK
CARBOGEN AMCIS
Scopri le nostre capacità di produzione di ingredienti cosmetici, prodotti di chimica fine e capacità di sintesi personalizzata di intermedi farmaceutici.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
REGIONE: Europe
SERVIZI: Analytical / QC services, Manufacturing services, Development services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
COMPLIANCE: ECOVADIS, ISO, Consiglio di ricerca halal
CARBOGEN AMCIS | Aarau
CARBOGEN AMCIS
Sviluppo e produzione cGMP su media scala inclusa la cromatografia.
DIMENSIONE DEL LOTTO: Piccolo, Medio
COMPLIANCE: PMDA/MHLW (Japan GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), FDA (cGMP), ISO
CATEGORIA / PRODOTTO: SERVICES, PARTICLE ENGINEERING, BIOLOGIA, CHEMICAL-SYNTHETIC
REGIONE: Europe
MERCATI: ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Manufacturing services, Development services, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
Apeloa Pharmaceutical Co., Ltd.
Apeloa Pharmaceutical Co., Ltd
Apeloa CDMO fornisce servizi di scoperta, sviluppo e produzione di livello mondiale per API, prodotti intermedi e RSM.
MERCATI: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
COMPLIANCE: EMA (GMP UE), PMDA/MHLW (Japan GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), FDA (cGMP), NMPA (Cina GMP), ECOVADIS, ISO
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging
REGIONE: APAC
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
CATEGORIA / PRODOTTO: CHEMICAL-SYNTHETIC
Sichuan Huiyu Pharmaceuticals Co., Ltd. - API Manufacturing Site
Seacross Pharmaceutical Co Ltd
Essendo uno dei tre siti principali, insieme al centro di ricerca e sviluppo e all'impianto di formulazione, il nostro impianto di produzione di API svolge un r
MERCATI: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
COMPLIANCE: ISP (Chile BPM), Roszdravnadzor (Russia GMP), ANMAT (nuove BPF dell'Argentina), EMA (GMP UE), PMDA/MHLW (Japan GMP), IFS, DIGEMID, UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), MHRA (UK GMP), Servizio pubblico francese (CIR), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (Cina GMP), SFDA (Saudi Food & Drug Authority), BRCGS, ECOVADIS, ISO, Consiglio di ricerca halal, INVIMA, Health Canada (Canada GMP), SQF (alimenti di qualità sicuri), TITCK (Turkish Health Authorities), MSPAS, MFDS/KFDA (Repubblica di Corea GMP), COFEPRIS
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
BSL (Livello di sicurezza biologica): 3, 4, 1, 2
USO: Umano
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIONE: APAC
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
CATEGORIA / PRODOTTO: CHEMICAL-SYNTHETIC